Patient-Focused Drug Development: Engaging Patients to Spark Real Change
183 views · Published 15 November 2018 · 48:02 · Indexed 20 September 2026
Channel: Dana-Farber Cancer Institute · 2018 · Science & Technology
Moderated by Dana-Farber’s President & CEO, Laurie H. Glimcher, MD, Giovanni Caforio, MD, George D. Demetri, MD, FACP, FASCO, Katherine A. Janeway, MD, MMSc, and John Maraganore, PhD, discuss how patient-focused drug development can accelerate new lifesaving medicines.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute